Literature DB >> 7958047

Beneficial effects of acarbose on daily plasma glucose profile and cataract development in sand rats.

Z Madar1, A Hazan, A Pollack.   

Abstract

Sand rats were used as a model for nutritionally induced type II (non-insulin-dependent) diabetes in an effort to evaluate the effect of acarbose on carbohydrate digestion. Daily plasma glucose profiles, insulin levels and weekly cararact development were determined following long-term feeding with a diet containing acarbose (20 or 40 mg/100 g diet). Acarbose not only dramatically decreased daily plasma glucose and insulin levels (p < 0.05) but also delayed, and possibly prevented, cataract formation in sand rats. The effect of acarbose persisted for 150 days. The control of daily plasma glucose levels and reduction of insulin levels obtained with acarbose may lead to the delay of cataract formation in sand rats. These results could have potential applications to diabetic patients as an adjunct treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7958047     DOI: 10.1038/eye.1994.74

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  2 in total

1.  Cap-independent translation: A shared mechanism for lifespan extension by rapamycin, acarbose, and 17α-estradiol.

Authors:  Ziqian Shen; Abby Hinson; Richard A Miller; Gonzalo G Garcia
Journal:  Aging Cell       Date:  2021-03-20       Impact factor: 9.304

2.  Rapamycin, Acarbose and 17α-estradiol share common mechanisms regulating the MAPK pathways involved in intracellular signaling and inflammation.

Authors:  Lily Wink; Richard A Miller; Gonzalo G Garcia
Journal:  Immun Ageing       Date:  2022-02-01       Impact factor: 6.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.